Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
公司代码LFCR
公司名称Lifecore Biomedical Inc
上市日期Feb 15, 1996
CEOJosephs (Paul)
员工数量406
证券类型Ordinary Share
年结日Feb 15
公司地址3515 Lyman Boulevard
城市CHASKA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编55318
电话19523684300
网址https://www.lifecore.com/
公司代码LFCR
上市日期Feb 15, 1996
CEOJosephs (Paul)